OS THERAPIES INCORPORATED Shares Outstanding
OS THERAPIES INCORPORATED (OSTX) had Shares Outstanding of 45.28 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-14
- 2026-06-30: Shares outstanding (split-adjusted) 45.28M shares; Shares authorized (split-adjusted) 150.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 39.28M shares; Shares authorized (split-adjusted) 150.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 37.11M shares; Shares authorized (split-adjusted) 150.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 33.27M shares; Shares authorized (split-adjusted) 50.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 45.28M shares 10-Q · filed 2026-08-14 | 150.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 39.28M shares 10-Q · filed 2026-05-18 | 150.00M shares 10-Q · filed 2026-05-18 |
| 2025-12-31 | 37.11M shares 10-Q · filed 2026-08-14 | 150.00M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 33.27M shares 10-Q · filed 2025-11-14 | 50.00M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 29.66M shares 10-Q · filed 2025-08-18 | 50.00M shares 10-Q · filed 2025-08-18 |
| 2025-03-31 | 21.35M shares 10-Q · filed 2025-05-15 | 50.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 20.87M shares 10-K · filed 2026-03-31 | 150.00M shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 21.18M shares 10-Q · filed 2024-11-15 | 50.00M shares 10-Q · filed 2024-11-15 |
| 2024-06-30 | 5.99M shares 10-Q · filed 2024-08-14 | 50.00M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 11.98M shares 10-Q · filed 2024-05-20 | 50.00M shares 10-Q · filed 2024-05-20 |
| 2024-02-09 | (m) | 50.00M shares 10-Q · filed 2024-08-14 |
| 2023-12-31 | 5.34M shares 10-K · filed 2025-03-31 | 50.00M shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |